210 related articles for article (PubMed ID: 12046039)
1. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
Gohda T; Shou I; Fukui M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
[TBL] [Abstract][Full Text] [Related]
2. Non-relation of parathyroid hormone gene polymorphisms to secondary hyperparathyroidism in Chinese hemodialysis patients.
Chen JB; Chou FF; Hsu KT
Ren Fail; 2004 Jan; 26(1):49-53. PubMed ID: 15083922
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients.
Nagaba Y; Heishi M; Tazawa H; Tsukamoto Y; Kobayashi Y
Am J Kidney Dis; 1998 Sep; 32(3):464-9. PubMed ID: 9740163
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients.
Borràs M; Torregrossa V; Oliveras A; Almirall J; Ma Paz M; Betriu A; Martin M; Muray S; Fibla J; Fernández E
J Nephrol; 2003; 16(1):116-20. PubMed ID: 12649542
[TBL] [Abstract][Full Text] [Related]
6. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism.
Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K
Clin Endocrinol (Oxf); 1999 May; 50(5):583-8. PubMed ID: 10468923
[TBL] [Abstract][Full Text] [Related]
8. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
Baradaran A; Nasri H
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between polymorphism of parathyroid hormone and bone mineral density and relevant biochemical indicators in women].
Zhong N; Zhang H; Wu XP; Luo XH; Xie H; Cao XZ; Shan PF; Liu H; Pi YZ; Fang TY; Liao EY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):376-9. PubMed ID: 16677544
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
12. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
13. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
14. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
Liou HH; Chiang SS; Huang TP; Shieh SD; Akmal M
Miner Electrolyte Metab; 1994; 20(3):97-102. PubMed ID: 7816008
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
[TBL] [Abstract][Full Text] [Related]
16. Association between parathyroid hormone (PTH)/PTH-related peptide receptor gene polymorphism and the extent of bone mass reduction in primary hyperparathyroidism.
Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K
Horm Metab Res; 2000 Sep; 32(9):355-8. PubMed ID: 11014383
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
[TBL] [Abstract][Full Text] [Related]
18. Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitrol in hemodialysis patients.
Marco MP; Martínez I; Betriu A; Craver L; Fibla MJ; Fernández E
Clin Nephrol; 2001 Aug; 56(2):111-6. PubMed ID: 11522087
[TBL] [Abstract][Full Text] [Related]
19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
20. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
